Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
出版年份 2020 全文链接
标题
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
作者
关键词
-
出版物
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-04-01
DOI
10.1093/ndt/gfaa088
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
- (2019) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies
- (2019) Roberto Minutolo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial
- (2019) Francesco Locatelli et al. Clinical Journal of the American Society of Nephrology
- Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis
- (2017) Laura Amato et al. JOURNAL OF NEPHROLOGY
- Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis
- (2017) Simon D Roger et al. NEPHROLOGY
- Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
- (2017) Bruce M. Robinson et al. BMC Nephrology
- Mortality Risk of Darbepoetin Alfa Versus Epoetin Alfa in Patients With CKD: Systematic Review and Meta-analysis
- (2015) Emilee R. Wilhelm-Leen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care
- (2015) Luca De Nicola et al. PLoS One
- Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?
- (2014) Luca De Nicola et al. DRUGS
- Pharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin
- (2014) Frieder Keller et al. Expert Opinion on Drug Metabolism & Toxicology
- Cumulative iron dose and resistance to erythropoietin
- (2014) A. Rosati et al. JOURNAL OF NEPHROLOGY
- Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
- (2013) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
- (2013) José Portolés et al. BMC Nephrology
- Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy
- (2011) L. De Nicola et al. Clinical Journal of the American Society of Nephrology
- Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
- (2010) Jodie L. Babitt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Prevalence and Prognosis of Mild Anemia in Non-Dialysis Chronic Kidney Disease: A Prospective Cohort Study in Outpatient Renal Clinics
- (2010) Luca De Nicola et al. AMERICAN JOURNAL OF NEPHROLOGY
- Conversion of Darbepoetin to Low Doses of CERA Maintains Hemoglobin Levels in Non-Dialysis Chronic Kidney Disease Patients
- (2010) Roberto Minutolo et al. BLOOD PURIFICATION
- International trends in erythropoietin use and hemoglobin levels in hemodialysis patients
- (2010) Philip A. McFarlane et al. KIDNEY INTERNATIONAL
- Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
- (2010) F. Carrera et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Low- Versus Moderate-Protein Diet on Progression of CKD: Follow-up of a Randomized Controlled Trial
- (2009) Bruno Cianciaruso et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
- (2009) P. E. Pergola et al. Clinical Journal of the American Society of Nephrology
- Epoetin Therapy and Hemoglobin Level Variability in Nondialysis Patients with Chronic Kidney Disease
- (2009) R. Minutolo et al. Clinical Journal of the American Society of Nephrology
- Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortality
- (2009) N. C. Boudville et al. Clinical Journal of the American Society of Nephrology
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
- (2008) R. D. Kilpatrick et al. Clinical Journal of the American Society of Nephrology
- Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study
- (2008) José M. Portolés et al. KIDNEY INTERNATIONAL
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
- (2008) Nosratola D Vaziri Nature clinical practice. Nephrology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search